Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹132 Cr
Revenue (TTM)
₹740 Cr
Net Profit (TTM)
₹-11 Cr
ROE
-11.6 %
ROCE
0.9 %
P/E Ratio
--
P/B Ratio
0.3
Industry P/E
21.45
EV/EBITDA
12.9
Div. Yield
0 %
Debt to Equity
1.4
Book Value
₹187.1
EPS
₹36.2
Face value
10
Shares outstanding
23,545,231
CFO
₹1,226.78 Cr
EBITDA
₹1,017.92 Cr
Net Profit
₹-993.46 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bilcare
| -29.7 | -14.0 | -26.1 | -23.1 | 5.9 | 1.7 | 3.4 |
|
BSE Commodities
| -5.4 | -9.2 | -2.4 | 6.9 | 14.9 | 13.0 | 15.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Bilcare
| 13.8 | -18.5 | 108.0 | -54.4 | 89.5 | 116.7 | -41.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bilcare
|
56.0 | 131.8 | 739.9 | -40.9 | -1.7 | 18.5 | -- | 0.3 |
| 67.6 | 169.9 | 129.0 | 2.3 | 0.6 | 2.3 | 76.7 | 1.6 | |
| 501.9 | 3,249.8 | 2,627.8 | 332.9 | 16.2 | 15.6 | 9.8 | 1.4 | |
| 621.7 | 1,628.5 | 3,363.9 | 146.2 | 6.2 | 9.7 | 11.1 | 1.0 | |
| 188.4 | 6,028.7 | 4,568.0 | 402.5 | 12.5 | 16.6 | 15.1 | 2.2 | |
| 1,007.6 | 4,405.8 | 3,285.2 | -252.8 | -6.6 | -4.9 | -- | 1.1 | |
| 853.4 | 2,674.2 | 6,954.7 | -5.4 | -1.1 | 0.8 | 88.4 | 0.7 | |
| 148.4 | 545.0 | 657.3 | 25.4 | 5.7 | 9.9 | 21.4 | 2.0 | |
| 157.2 | 7,760.0 | 5,897.3 | 454.1 | 11.6 | 15 | 17.4 | 2.0 |
2 min read•By Jatin Khemani
3 min read•By Research Desk
Bilcare Limited provides pharmaceutical packaging research solutions and global clinical services in India and internationally. The company offers various specialty polymer films and aluminum foils primarily used for packaging solid dosage... pharmaceutical products; and other packaging films solutions for applications in ID card, specialty film, and food packaging industries. It also provides clinical trial materials supplies and project management services; and nonClonableID, an anti-counterfeiting, security, and brand protection solution for various industry sectors. The company serves pharmaceutical and biotechnology industries. Bilcare Limited was incorporated in 1987 and is based in Pune, India. Read more
Incorporated
1987
Chairman
Shreyans Bhandari
Managing Director
Shreyans Bhandari
Group
Caprihans India - MNC
Headquarters
Pune, Maharashtra
Website
Annual Reports
The share price of Bilcare Ltd is ₹55.99 (BSE) as of 19-Mar-2026 IST. Bilcare Ltd has given a return of 5.85% in the last 3 years.
Since, TTM earnings of Bilcare Ltd is negative, P/E ratio is not available.
The P/B ratio of Bilcare Ltd is 0.30 times as on 19-Mar-2026, a 81 discount to its peers’ median range of 1.60 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.46
|
|
2024
|
0.00
|
0.27
|
|
2023
|
6.80
|
0.50
|
|
2022
|
0.00
|
2.19
|
|
2021
|
0.00
|
1.57
|
The 52-week high and low of Bilcare Ltd are Rs 116.00 and Rs 53.02 as of 20-Mar-2026.
Bilcare Ltd has a market capitalisation of ₹ 132 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Bilcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.